1-2 of 2
Danielle Leão, MD
Close
Sort by
Journal Articles

Superiority of Triple Combination Bortezomib + Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide + Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients

Edvan De Queiroz Crusoe, Fabiana Higashi, MD, Gracia Martinez, MD, Rosane Bittencourt, MD, Angelo Maiolino, MD, Lais Sousa, MD, Renata Ferreira Marques Nunes, MD, Glaciano Ribeiro, MD, Jandir Nicacio, MD, Karla Richter Zanella, MD, Andre Magalhaes, MD, Danielle Leao, MD, Jorge Vaz Pinto Neto, MD, Abrahão Elias Hallack Neto, MD PhD, Walter Braga, MD, Emmanuella G Souza, MD, Antonio Julio A.M. Guimaraes, MD, Giovanna Steffenello Durigon, MD, Dani Laks, MD PhD, Jose Mauro Kutner, MD PhD, Gilberto Colli, MD, Rodrigo Santucci, MD, Roberto José Pessoa Magalhães, MD, Vania T M Hungria, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5527.
https://doi.org/10.1182/blood.V130.Suppl_1.5527.5527
Published: 2017
Journal Articles

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Monika Conchon, MD, PhD, Renato S Tavares, MD, Katia B. Pagnano, MD, PhD, Tarcila S Datoguia, MD, Israel Bendit, MD, PhD, Marcia Torresan Delamain, MD, Irene Lorand-Metze, MD, PhD, Danielle Leão, MD, Jose Salvador Rodrigues, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5255.
https://doi.org/10.1182/blood.V122.21.5255.5255
Published: 2013